BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33349427)

  • 1. [French ccAFU guidelines - update 2020-2022: testicular germ cell tumors].
    Murez T; Fléchon A; Savoie PH; Rocher L; Camparo P; Morel-Journel N; Ferretti L; Méjean A
    Prog Urol; 2020 Nov; 30(12S):S280-S313. PubMed ID: 33349427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [French ccAFU guidelines - Update 2018-2020: Testicular germ cell tumors].
    Murez T; Fléchon A; Savoie PH; Rocher L; Camparo P; Morel-Journel N; Ferretti L; Sèbe P; Méjean A
    Prog Urol; 2018 Nov; 28 Suppl 1():R149-R166. PubMed ID: 31610870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CCAFU french national guidelines 2016-2018 on testicular germ cell tumors].
    Durand X; Fléchon A; Murez T; Rocher L; Camparo P; Morel-Journel N; Savoie PH; Ferretti L; Sèbe P; Méjean A
    Prog Urol; 2016 Nov; 27 Suppl 1():S147-S165. PubMed ID: 27846929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. French AFU Cancer Committee Guidelines - Update 2022-2024: testicular germ cell cancer.
    Murez T; Fléchon A; Branger N; Savoie PH; Rocher L; Camparo P; Neuville P; Ferretti L; Van Hove A; Roupret M
    Prog Urol; 2022 Nov; 32(15):1066-1101. PubMed ID: 36400478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CCAFU Recommendations 2013: Testicular germ cell cancer].
    Durand X; Rigaud J; Avancès C; Camparo P; Fléchon A; Murez T; Sèbe P; Culine S; Iborra F; Mottet N; Coloby P; Soulié M;
    Prog Urol; 2013 Nov; 23 Suppl 2():S145-60. PubMed ID: 24485289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU — Actualisation 2018—2020 : tumeurs germinales du testicule French ccAFU guidelines — Update 2018—2020: Testicular germ cell tumors].
    Murez T; Fléchon A; Savoie PH; Rocher L; Camparo P; Morel-Journel N; Ferretti L; Sèbe P; Méjean A
    Prog Urol; 2018 Nov; 28(12S):S147-S164. PubMed ID: 30472999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and primary treatment of testicular tumor].
    Kliesch S
    Urologe A; 2004 Dec; 43(12):1494-9. PubMed ID: 15592706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
    Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
    J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
    Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
    Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stage-specific treatment for testicular germ cell tumours].
    Heidenreich A; Bokemeyer C; Souchon R
    Urologe A; 2009 Apr; 48(4):377-85. PubMed ID: 19252891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current management of stage I testicular germ cell tumors in a French cancer institute. A practice analysis over the 10 past years.
    Chanal E; Bouleftour W; Guillot A; Rowinski E; Bernichon E; Tremeau L; Lardon R; Lacroix B; Lorin S; Delorme G; Perraud Y; Armand C; Levigne F; Vallard A; Langrand-Escure J; Fournel P; Benoite M; Vassal C
    Bull Cancer; 2019 Dec; 106(12):1086-1093. PubMed ID: 31582176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer.
    Heidenreich A; Paffenholz P; Nestler T; Pfister D
    Oncol Res Treat; 2018; 41(6):370-378. PubMed ID: 29772568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countries.
    Saju SV; Radhakrishnan V; Ganesan TS; Dhanushkodi M; Raja A; Selvaluxmy G; Sagar TG
    Med Oncol; 2019 Feb; 36(3):28. PubMed ID: 30725328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testicular cancer.
    Nichols CR
    Curr Probl Cancer; 1998; 22(4):187-274. PubMed ID: 9743088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of testicular germ cell tumors relapse].
    Carbonnaux M; Vinceneux A; Peyrat P; Fléchon A
    Bull Cancer; 2020 Sep; 107(9):912-924. PubMed ID: 32653158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sexual dysfunctions of patients treated with orchidectmoy, chemotherapy and retroperitoneal lymphadenectomy, need for systematic andrological care?].
    Barkatz J; Kleinclauss F; Rigaud J; Bouchot O; Orillard É; Thiery-Vuillemin A; Mouillet G; Kalbacher E; Madec FX
    Bull Cancer; 2019 Oct; 106(10):915-922. PubMed ID: 31126677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical stage I synchronous bilateral testicular germ cell tumor with different histopathology: a case report.
    Salazar-Mejía CE; Wimer-Castillo BO; García-Arellano G; Garza-Guajardo R; Vidal-Gutiérrez O; Zayas-Villanueva OA; Vera-Badillo FE
    Pan Afr Med J; 2020; 37():319. PubMed ID: 33680279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
    Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
    Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
    Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
    Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.